Kazia Therapeutics Limited
KZIA
$3.30
-$0.2395-6.77%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.20% | -105.33% | 0.47% | -25.74% | 2.27% |
| Total Depreciation and Amortization | 0.20% | 0.85% | -0.46% | -1.92% | -2.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.20% | 539.31% | -0.46% | 131.09% | 2.26% |
| Change in Net Operating Assets | 0.21% | 1,018.09% | -0.48% | -56.91% | -2.27% |
| Cash from Operations | -0.21% | 48.29% | 0.48% | 2.20% | 2.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00% | -100.08% | 0.00% | -- | -- |
| Total Debt Repaid | 0.00% | 100.22% | 0.00% | -- | -- |
| Issuance of Common Stock | 0.00% | -72.41% | 0.00% | -37.93% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 82.61% | 0.00% | 19.96% | 0.00% |
| Cash from Financing | 0.20% | -73.84% | -0.48% | -34.57% | -2.27% |
| Foreign Exchange rate Adjustments | 0.28% | 213.38% | 0.63% | -219.25% | -2.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.21% | -14.53% | 0.47% | -293.45% | -2.27% |